Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats (Q43508159)

24 November 2017

title

Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats (English)

1 reference

24 November 2017

1 reference

Laemont KD

1 reference

24 November 2017

Schaefer CJ

series ordinal

1 reference

24 November 2017

Juneau PL

series ordinal

1 reference

24 November 2017

Schrier DJ

series ordinal

1 reference

24 November 2017

publication date

1 November 1999

1 reference

International Journal of Immunopharmacology

24 November 2017

published in

1 reference

24 November 2017

1 reference

24 November 2017

1 reference

24 November 2017

page(s)

711-725

1 reference

Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: Modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Oxpentifylline inhibits tumor necrosis factor‐α mRNA transcription and protects against arthritis in mercuric chloride‐treated Brown Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reactions in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Endothelial cells and the pathogenesis of rheumatoid arthritis in humans and streptococcal cell wall arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Effects of adrenalectomy on serotonin-, somatostatin-, and gastrin-immunoreactive cells in rat gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2899%2900046-6

7 January 2021

10.1016/S0192-0561(99)00046-6

Identifiers

DOI

1 reference

24 November 2017

1 reference